Contents
Aurora Cannabis (NYSE: ACB) stock is down 7.6% today after the company announced it is selling its Costa Rica farm.
Checkout this video:
Aurora Cannabis Inc.
Aurora Cannabis Inc. is a Canadian cannabis company, founded in 2013. They are headquartered in Edmonton, Alberta, and trade on both the Toronto Stock Exchange and the New York Stock Exchange under the symbol ACB. As of June 2018, they had a market capitalization of $9.1 billion.
Overview
Aurora Cannabis Inc. is a Canadian cannabis company, founded in 2013 by Terry Booth and Steve Dobler. The company is headquartered in Edmonton, Alberta, Canada. Aurora Cannabis is one of the world’s largest cannabis companies with operations in 24 countries.
The company trades on the Toronto Stock Exchange under the ticker symbol “ACB”, and on the New York Stock Exchange under the ticker symbol “ACBFF”. As of July 2018, Aurora Cannabis had a market capitalization of over US$8 billion.
Aurora Cannabis is a member of the Cannabis industry association Canopy Growth Corporation (TSX:WEED), and the first Canadian company to be accepted into The Yield Growth Corporation (TSXV:BOSS).
History
Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton, Alberta. Aurora’s common shares trade on the Toronto Stock Exchange and the New York Stock Exchange under the symbol “ACB”.
The company has operations in 24 countries across five continents. Aurora Cannabis is one of the world’s largest cannabis companies with a production capacity of more than 625,000 kilograms per year and sales and operations in 14 countries. The company produces and sells dried cannabis and cannabis oil products under a variety of brands. Its products are sold through its online store and a network of retailers.
Aurora Cannabis was founded in 2013 by Terry Booth and Steve Dobler. The company’s US expansion began in early 2018 with the establishment of a production facility in Odessa, Florida. In November 2018, the company acquired MedReleaf Corp., which added to its international footprint and production capacity.
Business Model
Aurora Cannabis is a Canadian licensed cannabis producer, founded in 2013. The company trades on both the Toronto Stock Exchange and the New York Stock Exchange under the ticker symbol ACB. As of June 2018, Aurora Cannabis had a market capitalization of $9.5 billion.
Aurora Cannabis’ business model is focused on the medical cannabis market. The company produces and sells dried cannabis and cannabis oil products through its subsidiary, CanniMed Therapeutics Inc. Aurora also has agreements in place to sell products through Shoppers Drug Mart, the largest pharmacy chain in Canada. In addition to dried cannabis and cannabis oil, Aurora also produces and sells hemp-based food products through its subsidiary, Hempco Food and Fiber Inc.
Aurora Cannabis Stock
Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) stock was down 12.8% on Monday morning after closing at $8.23 on Friday. The stock has been on a roller coaster ride this year, and it’s down 64% since the beginning of 2020. Aurora Cannabis is a Canadian cannabis company that produces and sells medical and recreational cannabis products.
Stock Price
Aurora Cannabis Inc. is a Canadian cannabis company, founded in 2013. Aurora’s common shares trade on the Toronto Stock Exchange and the New York Stock Exchange under the symbol “ACB”, and are a constituent of the S&P/TSX Composite Index. As of May 2019, Aurora Cannabis had a market capitalization of over $8 billion.
Aurora Cannabis is one of the world’s largest cannabis companies with sales and operations in24 countries across five continents. The Company operates a 55,200 square foot flagship production facility in Mountain View County, Alberta, Canada, called “Aurum”, and a 31,000 square foot production facility in Pointe-Claire, Quebec, called “Spectrum Health”
In February 2018, Aurora completed the world’s largest cannabis deal valued at $852 million to acquire CanniMed Therapeutics. The Company has completed seven strategic acquisitions since entering into the U.S. market in October 2018 including MedReleaf (now Aurora Cornerstone), Larssen Greenhouses (now Aurora Sun), Anandia Laboratories and Urban Cultivator.
Market Cap
Aurora Cannabis has a market capitalization of $5.51 billion, making it the second-largest Canadian cannabis company by market cap. The company’s share price is down 13.73% on the TSX over the past year, but Aurora Cannabis stock is up 28.57% in 2020 so far.
Trading Volume
Aurora Cannabis Inc (NYSE: ACB) stock saw heavy trading volume on Thursday, with 49.7 million shares changing hands. That’s nearly three times the stock’s average daily volume and enough to make it one of the most actively traded stocks on the NYSE today.
The surge in trading volume comes as Aurora Cannabis stock continues to find support near the $5 level. ACB stock is down more than 80% from its 52-week high of $12.51, and shares have been under pressure in recent weeks after a disappointing earnings report and guidance cuts from management.
Despite the challenges, Aurora Cannabis remains one of the largest and most diversified marijuana companies in the world, with operations in 21 countries across five continents. The company is also working to expand its footprint in the U.S., where it recently announced a strategic investment in CBD products maker Reliva LLC.
Aurora Cannabis News
Aurora Cannabis Inc. is a publicly traded Canadian company that produces and sells medical cannabis. As of September 2018, it is the second largest cannabis company in the world by market capitalization. The company has operations in 24 countries and produces and sells medical cannabis in 11 countries.
Recent News
Aurora Cannabis Inc. (ACB) stocks fell on Monday after the Canadian cannabis company announced that it is selling $230 million in convertible senior notes due 2025.
The notes will be sold to a group of investors in a private placement and are convertible into common shares at a price of $7.23 per share, Aurora said in a news release. The sale is expected to close on March 2.
Aurora said it plans to use the proceeds from the sale for general corporate purposes, which may include working capital, capital expenditures and other strategic initiatives.
“The additional flexibility that this provides us will be instrumental as we continue executing on our growth strategy and building long-term shareholder value,” chief financial officer Glen Ibbott said in the release.
ACB stock was down more than 6% in early trading Monday.
Analyst Opinions
It is common for publicly traded companies to receive analyst ratings and recommendations from investment firms. Large banks and research firms that specialize in the cannabis industry often issue these reports.
Aurora Cannabis Inc. (ACB:NYSE) is no different, with analysts offering their opinions on the company’s stock. Here’s a look at what some of the major firms are saying about Aurora Cannabis today.
Analysts at CIBC upgraded Aurora Cannabis to an “outperform” rating, saying the company is “well-positioned” to capitalize on the growth of the Canadian cannabis market. The firm has a C$21 price target on the stock, which represents a potential upside of nearly 30%.
Meanwhile, analysts at Cowen upgraded Aurora Cannabis to an “outperform” rating as well, citing increasing demand for recreational cannabis in Canada. The firm has a C$25 price target on the stock, which represents a potential upside of nearly 60%.
Aurora Cannabis Competitors
Aurora Cannabis (NYSE: ACB) is one of the largest cannabis companies in the world, with a market capitalization of $9.8 billion. The company is headquartered in Edmonton, Alberta, Canada, and it has operations in 21 countries. Aurora Cannabis is a leading producer of medical and recreational cannabis products. The company is also one of the largest suppliers of cannabis oils.
Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in the business of producing and selling legal marijuana in Canada. It operates through three segments: Cannabis, hemp, and other operations. The company sells its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers oil products consisting of vape pens and vape pen cartridges; and softgel capsules and hemp. In addition, the company provides co-packing and warehousing services. Canopy Growth Corporation was founded in 2014 and is headquartered in Smiths Falls, Canada.
Competitors: Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Hexo (HEXO), Tilray (TLRY)
Tilray
Tilray is a Canadian pharmaceutical and cannabis company with headquarters in Nanaimo, British Columbia, and offices in Toronto, Ontario. It is a subsidiary of the American private equity firm Privateer Holdings. Tilray produces medical cannabis and sells it in Canada and the European Union.
Aphria
While Aphria does not have the same international profile as some of its competitors, it is one of the leading suppliers of medical cannabis in Canada. The company is headquartered in Leamington, Ontario, and has several production facilities in the province.
Aphria was founded in 2014 by John Cervini and Cole Diamond, and it began trading on the Toronto Stock Exchange in 2016. The company has a market capitalization of CAD$5.75 billion (as of March 2019) and is one of the largest producers of medical cannabis in Canada.
Aphria’s main competitors are Canopy Growth Corporation, Aurora Cannabis, and Tilray.
Aurora Cannabis Products
Aurora Cannabis (NYSE: ACB) is a Canadian cannabis company, founded in 2013 by Terry Booth, Steve Dobler, and Dale Lesak. The company is headquartered in Edmonton, Alberta, with production facilities in Mountain View County, Alberta, Cremona, Alberta, and Lachute, Quebec. Aurora Cannabis is one of the world’s largest cannabis companies, with operations in 25 countries.
Cannabis Oil
Aurora Cannabis Oil is a concentrated form of cannabis that is typically consumed orally. It is made by extracting the cannabinoids, including THC and CBD, from the cannabis plant using a solvent. The oil can be ingested on its own or added to food or beverages. Aurora Cannabis Oil is different from CBD oil, which does not contain THC and is used for medicinal purposes.
cannabinoid ratio than traditional cannabis. recreational users prefer it for its increased potency and resultant psychoactive effects. However, it should be noted that consuming large amounts of THC can result in adverse effects such as anxiety and paranoia.
Softgels
Aurora Cannabis produces a wide variety of cannabis products, including softgels. Made with Aurora’s high-quality cannabis oil, our softgels provides a convenient and consistent way to ingest cannabis. Aurora’s softgels are available in a variety of CBD to THC ratios, as well as different sizes and potency levels, so you can find the perfect product for your needs.
Capsules
Aurora Cannabis Inc. is a publicly traded Canadian company that produces and sells medical cannabis. The company is headquartered in Edmonton, Alberta, and has operations in 19 countries around the world. Aurora trades on the Toronto Stock Exchange under the ticker ACB, and on the New York Stock Exchange under the ticker ACBFF.
Aurora’s product line includes dried cannabis, cannabis oil, and softgel capsules. The company also offers cannabidiol (CBD) products, such as creams, as well as THC-free CBD products. In addition to medical uses, Aurora’s products are also sold for recreational use in Canada and some US states.
Aurora’s shares have been volatile in 2019, but the stock is up about 20% since the beginning of the year. At its current price of around $9 CAD per share, Aurora has a market capitalization of about $9 billion CAD.
